Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-09-11, Stock:JNJ, The news for the past five days is as follows:
2018-09-04: NEWS1: Geron Stock Up More Than 200% in 2018 So Far: Here's Why.NEWS2: Geron Stock Up More Than 200% in 2018 So Far: Here's Why.NEWS3: Geron Stock Up More Than 200% in 2018 So Far: Here&apos;s Why.NEWS4: How Eli Lilly’s Elanco Performed in Q2 2018.
2018-09-05: NEWS1: 9 Best Dividend Stocks to Buy for Every Investor.NEWS2: 9 Best Dividend Stocks to Buy for Every Investor.NEWS3: J&J Submits NDA to the FDA for Depression Drug in Adults.NEWS4: How Abiomed’s Revenue Trended in the First Quarter.NEWS5: Analyzing Alexion Pharmaceuticals’ Operational Performance.NEWS6: Alexion’s Top Line Continues to Expand Significantly.NEWS7: 3 Biotech Stocks That Still Have Major Catalysts in September.NEWS8: 3 Biotech Stocks That Still Have Major Catalysts in September.NEWS9: Shire plc (SHPG) Ex-Dividend Date Scheduled for September 06, 2018.NEWS10: Shire plc (SHPG) Ex-Dividend Date Scheduled for September 06, 2018.NEWS11: 3 Biotech Stocks That Still Have Major Catalysts in September.NEWS12: 3 Top Stocks Under $10.NEWS13: 3 Top Stocks Under $10.NEWS14: 3 Dividend Stocks Perfect for Retirees.NEWS15: 3 Dividend Stocks Perfect for Retirees.NEWS16: 3 Dividend Stocks Perfect for Retirees.NEWS17: 3 Top Stocks Under $10.
2018-09-06: NEWS1: Large Cap Pharma Stocks Staging a Comeback in Second Half.NEWS2: Large Cap Pharma Stocks Staging a Comeback in Second Half.NEWS3: Recent Product Approvals Bode Well for Intuitive Surgical.NEWS4: Large Cap Pharma Stocks Staging a Comeback in Second Half.NEWS5: Analyzing Intuitive Surgical’s Operational Performance.NEWS6: What Alexion Pharmaceuticals’ Valuation Trend Indicates.NEWS7: Johnson & Johnson To Present At Barclays Conference; Webcast At 12:45 PM ET.NEWS8: Johnson & Johnson To Present At Barclays Conference; Webcast At 12:45 PM ET.NEWS9: Johnson & Johnson To Present At Wells Fargo Conference; Webcast At 9:45 AM ET.NEWS10: Johnson & Johnson To Present At Wells Fargo Conference; Webcast At 9:45 AM ET.NEWS11: J&J Submits NDA to the FDA for Depression Drug in Adults.NEWS12: J&J Submits NDA to the FDA for Depression Drug in Adults.
2018-09-07: NEWS1: Pharma Stock Roundup: NVS' Sandoz Deal, Pipeline Updates at AZN & Others in Focus.NEWS2: Pharma Stock Roundup: NVS' Sandoz Deal, Pipeline Updates at AZN & Others in Focus.NEWS3: Pharma Stock Roundup: NVS&apos; Sandoz Deal, Pipeline Updates at AZN & Others in Focus.NEWS4: How Tesaro Hopes to Tackle Lung Cancer.NEWS5: How Tesaro Hopes to Tackle Lung Cancer.NEWS6: Lilly, Teva, Pfizer & Others Await FDA Decisions in September.NEWS7: How Tesaro Hopes to Tackle Lung Cancer.NEWS8: What Intuitive Surgical’s Valuation Trend Indicates.NEWS9: J&J to work with India on compensation for recalled hip implants.
2018-09-10: NEWS1: Shire's ADHD Portfolio Remains Strong Amid Competition.NEWS2: Shire's ADHD Portfolio Remains Strong Amid Competition.NEWS3: Shire&apos;s ADHD Portfolio Remains Strong Amid Competition.NEWS4: Notable Monday Option Activity: JNJ, BA, QCOM.NEWS5: Notable Monday Option Activity: JNJ, BA, QCOM.NEWS6: See How Johnson & Johnson Ranks Among Analysts' Top Dow 30 Picks.NEWS7: See How Johnson & Johnson Ranks Among Analysts' Top Dow 30 Picks.NEWS8: Dow Analyst Moves: JNJ.NEWS9: Dow Analyst Moves: JNJ.NEWS10: Most Analysts Currently Call Boston Scientific a ‘Buy’.NEWS11: The Week Ahead: Apple's Special Event, Mobile World Congress, US Inflation Data On Deck.NEWS12: Perrigo's OTC Version of Diarrhea Drug Imodium Gets FDA Nod.NEWS13: Perrigo's OTC Version of Diarrhea Drug Imodium Gets FDA Nod.NEWS14: Novartis a Top Ranked SAFE Dividend Stock With 3.6% Yield.NEWS15: Novartis a Top Ranked SAFE Dividend Stock With 3.6% Yield.NEWS16: The Zacks Analyst Blog Highlights: Novartis, AstraZeneca, Merck, Pfizer and Johnson & Johnson.NEWS17: The Zacks Analyst Blog Highlights: Novartis, AstraZeneca, Merck, Pfizer and Johnson & Johnson.NEWS18: Perrigo&apos;s OTC Version of Diarrhea Drug Imodium Gets FDA Nod.NEWS19: The Zacks Analyst Blog Highlights: Novartis, AstraZeneca, Merck, Pfizer and Johnson & Johnson.

Answer: Rise